Jean-Pierre Sommadossi
CIK 1296995 · President, CEO, and Chairman · last filed 2026-02-03
Jean-Pierre Sommadossi is a President, CEO, and Chairman who has filed 21 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for AVIR, was dated Feb 3, 2026. Across all open-market trades the lifetime net is −$457.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $28.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$28.92M
3
21
-$457.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVIR | President, CEO, and Chairman | 6,439,948 | $4.49 | $28.92M | -$457.0K | 9 | 2026-02-03 |
| Kezar Life Sciences, Inc. (KZR) Delisted | Director | 143,182 | $7.29 | $1.04M | $0 | 4 | 2021-06-30 |
| IDENIX PHARMACEUTICALS INC (IDIX) Delisted | President, CEO, Chairman | 2,219,754 | — | — | $0 | 7 | 2010-02-11 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-03 | AVIR | Mixed | +466,890 | -$77.8K | EDGAR |
| 2025-02-04 | AVIR | Mixed | +184,383 | -$271.1K | EDGAR |
| 2024-09-19 | AVIR | Sell (S) | −57,969 | -$234.2K | EDGAR |
| 2024-06-07 | AVIR | Sell (S) | −1,006 | -$4.0K | EDGAR |
| 2024-02-02 | AVIR | Mixed | +116,557 | -$218.8K | EDGAR |
| 2023-03-03 | — | Disp (D) | — | $0 | |
| 2023-02-02 | AVIR | Grant (A) | — | $0 | EDGAR |
| 2022-02-02 | AVIR | Grant (A) | — | $0 | EDGAR |
| 2021-06-30 | Kezar Life Sciences, Inc. (KZR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-01 | AVIR | Grant (A) | — | $0 | EDGAR |